Combining the financial and the strategic…the unholy alliance between Takeda and TPG!

Last week saw the announcement of an attempted bid for Valeant, the serial acquirer masquerading as a pharmaceuticals company at a rather opportunistic time when the firestorm of media attention, debt levels, alleged pricing scandals and CEO ill health threatened to unhinge the business entirely. It’s not a first combination of this type…the acquisition of Boots by Alliance Unichem was financed largely by KKR in a similar sharing of interests. […]